Company
PrognomIQ
Reimagining early disease detection and treatment
- Business model
- B2B
- Legal name
- PrognomiQ, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
PrognomiQ is developing transformative test products that enable early disease detection and treatment. We do this by generating proprietary proteomic data at unparalleled volumes and depth of information. We then complement this extensive proteomic information with genomic, metabolomic, and other health data to discover innovative approaches to early disease detection that translate into transformative test products.
Funding snapshot
- Total raised
- $56.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $11.9M2026-01-02
Funding rounds
- Round, 2026
- $11.9M2026-01-02, SEC form D sold, 6 investors
- Round, 2025
- $10M2025-08-01, SEC form D sold, 9 investors
- Round, 2024
- $34.3M2024-08-12, SEC form D sold, 10 investors
Products
- Web
- ProVue Lung
Loading relationship preview